Correlation Engine 2.0
Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

Phosphofructokinase-M (PFKM) is a key enzyme in glycolysis. The expression and activity of PFKM is closely related to the occurrence and development of malignant tumors, but its role in the regulation of renal cell carcinoma (RCC) is still unknown. We found that the expression of PFKM was lower in RCC tumor tissue than in adjacent normal tissues, and that low expression of PFKM was related to the poor overall survival of RCC patients. In addition, our results showed that FOXO3 mediated PFKM inhibited the growth, migration and invasion of RCC cells, suggesting that PFKM is a protective factor for RCC. Copyright © 2020 Elsevier Inc. All rights reserved.


Yeda Chen, Qingfeng Yu, Xiaolu Duan, Wenqi Wu, Guohua Zeng. Phosphofructokinase-M inhibits cell growth via modulating the FOXO3 pathway in renal cell carcinoma cells. Biochemical and biophysical research communications. 2020 Sep 10;530(1):67-74

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 32828317

View Full Text